Cardiac Safety Services Market Detailed Analysis Report by Key Players and Forecast 2027

1
Cardiac Safety Services Market To Reach USD 895.7
Million by 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
The rising incidences of Cardiovascular
disorders, improved technological advances,
rising prevalence of heart related diseases,
rising geriatric population, new product
launches, and strategic collaboration, are key
factors contributing to the high CAGR of the
Cardiac Safety Services market during the
forecast period. Market Size USD 384.9 Million
in 2018, Market Growth - CAGR of 11 Market
Trends Favorable government funding scenario.
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global Cardiac Safety Services Market
  valued at USD 384.9 million in 2018 and is
  expected to reach USD 895.7 million by the year
  2026, at a CAGR of 11. Cardiac safety is the
  primary cause of the Clinical trial delay and
  drug abandonment. Cardiac Safety services are
  beneficial for monitoring the abnormalities of
  the heart. There has been a significant rise in
  the RD expenditure in the pharmaceutical
  biopharmaceutical industry and increased RD
  activities. The increase in the number of
  clinical trials is fuelling the growth of the
  market. Additionally, the advances of the new
  technologies in the cardiac services market are
  offering growth opportunities for players in the
  market. However, the high expenditure cost of
  cardiac safety evaluation is hindering the growth
  of the market.
• Biotrial (France), Banook Group (France
  Canada), Bioclinica (a subsidiary of Cinven, US),
  Certara L.P. (U.S.), Celerion, Inc. (U.S.), ERT,
  Inc. (U.S.), Laboratory Corporation of America
  Holdings (U.S.), Medpace Holdings, Inc. (U.S.),
  Ncardia AG (Belgium), Richmond Pharmacology
  (U.K.), PhysioStim (France), Shanghai Medicilon
  Inc. (China), Pharmaceutical Product Development
  LLC (U.S.), SGS S.A. (Switzerland), BioTelemetry,
  Inc. (U.S.), IQVIA (U.S.), OMRON Healthcare, Inc
  (Japan), Biobeat (U.S.) and InBody USA (U.S.),
  Microsoft (U.S.)
• To Get Sample Copy of Report visit
  https//www.reportsanddata.com/sample-enquiry-form
  /2707

4
Our Approach
Market Summary

• Product and Services Outlook (Revenue in Million
  USD 20172024)
• ECG/Holter Measurement
• Blood Pressure Measurement
• Cardiovascular Imaging
• Thorough Q.T. Studies
• Other Services
• Applications Outlook (Revenue in Million USD
  20172024)
• Integrated Services
• Standalone Services
• End Use Outlook (Revenue in Million USD
  20172024)
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Research Organizations
• Grab Your Report at an Impressive Discount!
  Please Click Here _at_ https//www.reportsanddata.com
  /discount-enquiry-form/2707

5
Our Approach
Market Summary

• Further key findings from the report suggest
• Microsoft had launched Microsoft Hololens it
  enables the measurement and visualization of
  blood flow. Microsoft Hololens do not require any
  tethering device or any additional hardware. The
  system includes a front-facing camera, remote
  imaging photoplethysmography software it allows
  the users to view the physiological state of a
  person by simply looking at them. The blood Flow
  is measured by just looking at the appearance of
  the subject.
• Acoalition of professional societies had
  developed the AUC (Appropriate use criteria) for
  cardiac imaging to standardize the cardiac
  imagining system for patients with congenital
  heart disease it was developed by the American
  College of Cardiology (ACC), American Heart
  Association (AHA), American Society of
  Echocardiography, and the International Society
  for Adult Congenital Heart Disease, AUC provides
  guidelines to the clinicians to understand the
  relative risks and benefits of various
  cardiovascular procedures it also guidelines to
  understand the risk tetralogy of Fallot,
  transposition, or atrial septal defects
• ERT in the year 2018 had launched a Cardiac
  Safety Center and is also the first to do it
  they offer cardia safety assessment in Phase 1
  studies using integrated ECG analysis. They had
  used the Icardiac Technologies for obtaining a
  precise ECG data using an ERT Expert technology
  platform.
• Read More _at_ https//www.reportsanddata.com/report-
  detail/cardiac-safety-services-market

6
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com